• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六分钟步行试验的普及性肺功能估计系统。

A Pervasive Pulmonary Function Estimation System with Six-Minute Walking Test.

机构信息

Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan.

Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung 407, Taiwan.

出版信息

Biosensors (Basel). 2022 Oct 4;12(10):824. doi: 10.3390/bios12100824.

DOI:10.3390/bios12100824
PMID:36290960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9599376/
Abstract

Self-monitoring for spirometry is beneficial to assess the progression of lung disease and the effect of pulmonary rehabilitation. However, home spirometry fails to meet both accuracy and repeatability criteria in a satisfactory manner. The study aimed to propose a pervasive spirometry estimation system with the six-minute walking test (6MWT), where the system with information management, communication protocol, predictive algorithms, and a wrist-worn device, was developed for pulmonary function. A total of 60 subjects suffering from respiratory diseases aged from 25 to 90 were enrolled in the study. Pulmonary function test, walking steps, and physical status were measured before and after performing the 6MWT. The significant variables were extracted to predict per step distance (PSD), forced vital capacity (FVC) and forced expiratory volume in one second (FEV). These predicted formulas were then implemented in a wrist-worn device of the proposed pervasive estimation system. The predicted models of PSD, and FVC, FEV with the 6MWT were created. The estimated difference for PSD was-0.7 ± 9.7 (cm). FVC and FEV before performing 6MWT were 0.2 ± 0.6 (L) and 0.1 ± 0.6 (L), respectively, and with a sensitivity (Sn) of 81.8%, a specificity (Sp) of 63.2% for obstructive lung diseases, while FVC and FEV after performing the 6MWT were 0.2 ± 0.7 (L) and 0.1 ± 0.6 (L), respectively, with an Sn of 90.9% and an Sp of 63.2% for obstructive lung diseases. Furthermore, the developed wristband prototype of the pulmonary function estimation system was demonstrated to provide effective self-estimation. The proposed system, consisting of hardware, application and algorithms was shown to provide pervasive assessment of the pulmonary function status with the 6MWT. This is a potential tool for self-estimation on FVC and FEV for those who cannot conduct home-based spirometry.

摘要

自我监测肺功能对于评估肺部疾病的进展和肺康复的效果是有益的。然而,家庭肺功能测试在准确性和可重复性方面都不能令人满意地满足标准。本研究旨在提出一种普及性的肺功能估计系统,结合六分钟步行测试(6MWT),该系统包括信息管理、通信协议、预测算法和腕戴设备,用于肺功能。共有 60 名年龄在 25 岁至 90 岁之间患有呼吸系统疾病的患者参加了这项研究。在进行 6MWT 前后,测量了肺功能测试、步行步数和身体状况。提取了显著变量来预测每步距离(PSD)、用力肺活量(FVC)和第一秒用力呼气量(FEV)。然后,将这些预测公式应用于所提出的普及性估计系统的腕戴设备中。创建了基于 6MWT 的 PSD、FVC 和 FEV 的预测模型。PSD 的估计差异为-0.7 ± 9.7(cm)。在进行 6MWT 之前,FVC 和 FEV 分别为 0.2 ± 0.6(L)和 0.1 ± 0.6(L),对于阻塞性肺部疾病的灵敏度(Sn)为 81.8%,特异性(Sp)为 63.2%,而在进行 6MWT 之后,FVC 和 FEV 分别为 0.2 ± 0.7(L)和 0.1 ± 0.6(L),对于阻塞性肺部疾病的 Sn 为 90.9%,Sp 为 63.2%。此外,还展示了用于肺功能估计系统的腕带原型,该原型被证明可以提供有效的自我估计。该系统由硬件、应用程序和算法组成,被证明可以通过 6MWT 对肺功能状态进行普及性评估。对于那些无法进行家庭肺功能测试的人来说,这是一种用于 FVC 和 FEV 自我估计的潜在工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/9591fb6ad86f/biosensors-12-00824-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/79f02d942629/biosensors-12-00824-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/a0c59966fca7/biosensors-12-00824-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/374818af3290/biosensors-12-00824-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/35b5022337e4/biosensors-12-00824-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/9591fb6ad86f/biosensors-12-00824-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/79f02d942629/biosensors-12-00824-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/a0c59966fca7/biosensors-12-00824-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/374818af3290/biosensors-12-00824-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/35b5022337e4/biosensors-12-00824-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ae1/9599376/9591fb6ad86f/biosensors-12-00824-g005.jpg

相似文献

1
A Pervasive Pulmonary Function Estimation System with Six-Minute Walking Test.六分钟步行试验的普及性肺功能估计系统。
Biosensors (Basel). 2022 Oct 4;12(10):824. doi: 10.3390/bios12100824.
2
Study the association between spirometry based functional grading and six minute walk distance in chronic respiratory disease patients at a rural tertiary care centre of India.研究印度农村三级保健中心慢性呼吸疾病患者基于肺功能分级的功能分级与 6 分钟步行距离之间的关系。
Ann Afr Med. 2023 Oct-Dec;22(4):526-531. doi: 10.4103/aam.aam_19_23.
3
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。
Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.
4
Difference Between Slow and Forced Vital Capacity and Its Relationship with Dynamic Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease.慢肺活量和强迫肺活量的差异及其与慢性阻塞性肺疾病患者动态过度充气的关系。
Lung. 2019 Feb;197(1):9-13. doi: 10.1007/s00408-018-0174-y. Epub 2018 Oct 29.
5
[Expression of serous fibroblast growth factor 7 and related inflammatory factors in patients with acute exacerbation of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重期患者血清成纤维细胞生长因子7及相关炎症因子的表达]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Apr;33(4):421-426. doi: 10.3760/cma.j.cn121430-20201231-00786.
6
A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.一项基于医院的关于慢性阻塞性肺疾病及其他疾病患者肺功能测试和运动耐量的研究。
J Indian Med Assoc. 2007 Oct;105(10):565-6, 568, 570 passim.
7
Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.在韩国人群中,使用FEV1/FEV6作为FEV1/FVC的替代指标来检测气道阻塞的截断值。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 19;11:1957-63. doi: 10.2147/COPD.S113568. eCollection 2016.
8
Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.预测肺活量测定技术不充分以及将FEV1/FEV3作为轻度认知障碍患者FEV1/FVC的替代指标。
Clin Respir J. 2008 Oct;2(4):208-13. doi: 10.1111/j.1752-699X.2008.00063.x.
9
Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.用力和缓慢肺活量测定在定义气道阻塞中的比较。
Respir Care. 2019 Jul;64(7):786-792. doi: 10.4187/respcare.06419. Epub 2019 Mar 19.
10
Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.通过比较FEV1/FVC和FEV1/FEV6比值,确定FEV6作为慢性阻塞性肺疾病诊断筛查中FVC替代指标的有效性。
J Bras Pneumol. 2007 Mar-Apr;33(2):148-51. doi: 10.1590/s1806-37132007000200008.

引用本文的文献

1
Multifaceted associations between walking performance, physical fitness, extremity function, health status, and depression in individuals with COPD.在 COPD 患者中,行走表现、身体机能、肢体功能、健康状况和抑郁之间存在多方面的关联。
Ann Med. 2024 Dec;56(1):2338248. doi: 10.1080/07853890.2024.2338248. Epub 2024 Apr 8.

本文引用的文献

1
Predicting Pulmonary Function From the Analysis of Voice: A Machine Learning Approach.通过语音分析预测肺功能:一种机器学习方法。
Front Digit Health. 2022 Feb 8;4:750226. doi: 10.3389/fdgth.2022.750226. eCollection 2022.
2
Benefits of Telemonitoring of Pulmonary Function-3-Month Follow-Up of Home Electronic Spirometry in Patients with Duchenne Muscular Dystrophy.杜氏肌营养不良症患者家庭电子肺量计肺功能远程监测的益处——3个月随访
J Clin Med. 2022 Feb 6;11(3):856. doi: 10.3390/jcm11030856.
3
Home-based spirometry in the self-management of chronic obstructive pulmonary disease.
家庭肺功能仪在慢性阻塞性肺疾病自我管理中的应用
Chin Med J (Engl). 2021 Apr 13;134(15):1789-1791. doi: 10.1097/CM9.0000000000001468.
4
Remote patient monitoring for ED discharges in the COVID-19 pandemic.新冠疫情期间急诊科出院患者的远程患者监测。
Emerg Med J. 2021 Mar;38(3):229-231. doi: 10.1136/emermed-2020-210022. Epub 2021 Jan 20.
5
Novel Coronavirus (COVID-19): telemedicine and remote care delivery in a time of medical crisis, implementation, and challenges.新型冠状病毒(COVID-19):医疗危机时期的远程医疗和远程护理服务,实施和挑战。
Transl Behav Med. 2021 Mar 16;11(2):659-663. doi: 10.1093/tbm/ibaa105.
6
The Effect of a Pulmonary Rehabilitation on Lung Function and Exercise Capacity in Patients with Burn: A Prospective Randomized Single-Blind Study.肺康复对烧伤患者肺功能和运动能力的影响:一项前瞻性随机单盲研究。
J Clin Med. 2020 Jul 15;9(7):2250. doi: 10.3390/jcm9072250.
7
Clusters of COVID-19 in long-term care hospitals and facilities in Japan from 16 January to 9 May 2020.2020 年 1 月 16 日至 5 月 9 日日本长期护理医院和设施中的 COVID-19 集群。
Geriatr Gerontol Int. 2020 Jul;20(7):715-719. doi: 10.1111/ggi.13973.
8
Variable selection strategies and its importance in clinical prediction modelling.变量选择策略及其在临床预测模型中的重要性。
Fam Med Community Health. 2020 Feb 16;8(1):e000262. doi: 10.1136/fmch-2019-000262. eCollection 2020.
9
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
10
Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps.通过地理信息系统地图展示的全球慢性阻塞性肺疾病患病率的地理分布。
Eur Respir J. 2019 Jul 18;54(1). doi: 10.1183/13993003.00610-2019. Print 2019 Jul.